Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors

• Hanwen Zhang ,

  * E-mail: zhangh1@mskcc.org

  Affiliations Division of Radiological Chemistry, Department of Radiology, University Hospital Basel, Basel, Switzerland, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Keelara Abiraj,

  Affiliation Translational Research Sciences, Pharma Research and Early Development (pRED), F Hoffmann-La Roche Ltd, Basel, Switzerland

  ⨯
• Daniel L. J. Thorek,

  Affiliation Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Beatrice Waser,

  Affiliation Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Berne, Switzerland

  ⨯
• Peter M. Smith-Jones,

  Affiliation Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Michael Honer,

  Affiliation Translational Research Sciences, Pharma Research and Early Development (pRED), F Hoffmann-La Roche Ltd, Basel, Switzerland

  ⨯
• Jean Claude Reubi,

  Affiliation Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Berne, Switzerland

  ⨯
• Helmut R. Maecke

  Affiliations Division of Radiological Chemistry, Department of Radiology, University Hospital Basel, Basel, Switzerland, Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany

  ⨯